healthcare & pharmaceutical
Molbio Diagnostics Enhances Cervical Cancer Screening
Molbio Diagnostics Limited, a pioneer in point-of-care molecular diagnostics, recently unveiled their latest innovation, Truenat® HPV-HR Plus, which enables expanded high-risk genotype detection. The chip-based RT-PCR test allows rapid and decentralized detection of eight high-risk genotypes of human papillomavirus (HPV) – which account for over 96% of cervical cancer cases globally.